Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

about

Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

P2860

Q48246121-1AA56D6B-F278-4024-AC2E-3A7CD4088F10 Q55334211-921B13A8-5388-47D0-B4E1-1A652CA00903

P2860

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

Item

http://www.wikidata.org/entity/Q39557726

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@en

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@nl

type

Item

label

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@en

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@nl

prefLabel

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@en

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@nl

P1476

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

@en

P2093

Anokhi Jambusaria-Pahlajani

http://www.w3.org/2001/XMLSchema#string

Jason C Sluzevich

http://www.w3.org/2001/XMLSchema#string

Matthew C Gordon

http://www.w3.org/2001/XMLSchema#string

P2860

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions

Immunomodulatory and pharmacologic properties of imiquimod.

Interferon in the treatment of cutaneous T-cell lymphoma.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma.

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.

Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides.

Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.

P304

348-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.JDCR.2015.08.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282283897

http://www.w3.org/2001/XMLSchema#string

P698

27051776

http://www.w3.org/2001/XMLSchema#string

P932

4809372

http://www.w3.org/2001/XMLSchema#string

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

about

P2860

P2860

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932